Deutsche Bank
KERX

Deutsche Bank’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Deutsche Bank’s Portfolio KERX Stock Details KERX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-550
Closed -$7K – 6439
2014
Q3 		$7K Buy
+550
New +$8.42K ﹤0.01% 5486

Deutsche Bank's KERX Position: Q4 2018 in Review

Deutsche Bank sold out of Keryx Biopharmaceuticals Inc (KERX) in Q4 2018, closing a stake of 609,809 shares — an estimated $2.07M sold.

Deutsche Bank first reported a position in KERX in Q2 2013 and held it in 22 quarters. The position peaked at $9.18M in Q3 2013. 1 fund tracked by Wall St. Rank holds KERX as of Q4 2018.

  • Deutsche Bank reported no remaining Keryx Biopharmaceuticals Inc position as of Q4 2018 after selling out during the quarter.
  • Deutsche Bank sold 609,809 Keryx Biopharmaceuticals Inc shares in Q4 2018, an estimated $2.07M.
  • Deutsche Bank first reported a position in Keryx Biopharmaceuticals Inc in Q2 2013 and held it in 22 quarters.
  • Deutsche Bank's Keryx Biopharmaceuticals Inc position peaked at $9.18M in Q3 2013.
  • 1 fund tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q4 2018.

Based on Deutsche Bank's 13F filing for Q4 2018, filed 14 Feb 2019.